Top ten highlights from the APAC PE, VC, and startup ecosystem this week:
- Southeast Asian startups experienced a decline in equity funding in the second quarter, marking a reversal from previous upward trends.
- In the first half of 2024, the total value of proceeds in the region stood at $2.29 billion, showing a 36% year-on-year decline, the lowest level in more than five years.
- Indonesia saw a significant drop in funding activities, with deal volume hitting a new low in the second quarter.
- Early-stage startup funding surpassed late-stage funding in the first semester, indicating a shift from the past five years.
- Indian startups raised the highest funding in June, with $2.24 billion compared to $1.85 billion in May 2024.
- Indian e-commerce startups dominated big-ticket funding transactions, securing $1.9 billion in the first half of 2024.
- Several companies in Southeast Asia reported financial updates, including 2C2P trimming its losses and Naver-backed Planetarium Labs experiencing revenue growth despite increased losses.
- Singapore’s GIC posted a 3.9% annualized real rate of return for the 20-year period ending in March 2024.
- ANEXT Bank in Singapore saw losses rise in 2023 despite a significant revenue increase.
- Overall, the venture capital landscape in Southeast Asia remains cautious, with investors eyeing opportunities in various sectors and markets.”
APAC Private Markets Research
Explore latest Insights on APAC Private Markets on Smartkarma
Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
Also, check out the latest in ECM Research on Smartkarma
